IL326135A - שיטות לטיפול בסרטן הערמונית באמצעות נוגדנים דו-ספציפיים הקושרים steap1 ו-cd3 - Google Patents
שיטות לטיפול בסרטן הערמונית באמצעות נוגדנים דו-ספציפיים הקושרים steap1 ו-cd3Info
- Publication number
- IL326135A IL326135A IL326135A IL32613526A IL326135A IL 326135 A IL326135 A IL 326135A IL 326135 A IL326135 A IL 326135A IL 32613526 A IL32613526 A IL 32613526A IL 326135 A IL326135 A IL 326135A
- Authority
- IL
- Israel
- Prior art keywords
- steap1xcd3
- methods
- prostate cancer
- bispecific antibodies
- antibodies binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363533824P | 2023-08-21 | 2023-08-21 | |
| PCT/US2024/042988 WO2025042865A1 (en) | 2023-08-21 | 2024-08-20 | Methods for treating prostate cancer with bispecific antibodies binding steap1xcd3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326135A true IL326135A (he) | 2026-03-01 |
Family
ID=92746201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326135A IL326135A (he) | 2023-08-21 | 2024-08-20 | שיטות לטיפול בסרטן הערמונית באמצעות נוגדנים דו-ספציפיים הקושרים steap1 ו-cd3 |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR20260057087A (he) |
| CN (1) | CN121794300A (he) |
| AU (1) | AU2024326785A1 (he) |
| CO (1) | CO2026003434A2 (he) |
| IL (1) | IL326135A (he) |
| MX (1) | MX2026002085A (he) |
| TW (1) | TW202515613A (he) |
| WO (1) | WO2025042865A1 (he) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ550816A (en) * | 2004-04-22 | 2009-12-24 | Agensys Inc | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| AU2007308792B2 (en) * | 2006-10-27 | 2013-01-24 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
| MX2020008219A (es) | 2018-02-08 | 2020-10-22 | Amgen Inc | Formulacion farmaceutica de ph bajo. |
| MY208638A (en) | 2018-07-02 | 2025-05-21 | Amgen Inc | Anti-steap1 antigen-binding protein |
| CN114929743B (zh) * | 2019-09-05 | 2026-01-02 | 纪念斯隆凯特琳癌症中心 | 抗steap1抗体及其用途 |
-
2024
- 2024-08-20 IL IL326135A patent/IL326135A/he unknown
- 2024-08-20 CN CN202480054406.XA patent/CN121794300A/zh active Pending
- 2024-08-20 AU AU2024326785A patent/AU2024326785A1/en active Pending
- 2024-08-20 WO PCT/US2024/042988 patent/WO2025042865A1/en active Pending
- 2024-08-20 TW TW113131245A patent/TW202515613A/zh unknown
- 2024-08-20 KR KR1020267008104A patent/KR20260057087A/ko active Pending
-
2026
- 2026-02-20 MX MX2026002085A patent/MX2026002085A/es unknown
- 2026-03-20 CO CONC2026/0003434A patent/CO2026003434A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20260057087A (ko) | 2026-04-27 |
| CO2026003434A2 (es) | 2026-04-06 |
| MX2026002085A (es) | 2026-04-01 |
| TW202515613A (zh) | 2025-04-16 |
| AU2024326785A1 (en) | 2026-02-12 |
| CN121794300A (zh) | 2026-04-03 |
| WO2025042865A1 (en) | 2025-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304275A (he) | שיטות לטיפול בסרטן | |
| IL312680A (he) | שיטות לטיפול בסרטן | |
| IL279251A (he) | שיטות לטיפול בסרטן עם נוגדנים דו-ספציפיים נגד cd3xmuc16 ונוגדנים נגד pd-1 | |
| IL276303A (he) | שיטות לטיפול בסרטן עם נוגדני anti-pd-1 | |
| IL320332A (he) | שיטות לטיפול בסרטן | |
| MX2021012767A (es) | Metodos para tratar el cancer de prostata con un anticuerpo anti-psma/cd3. | |
| IL299293A (he) | שיטות לטיפול בסרטן עם טיפולים משולבים | |
| SG11202108525VA (en) | Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind met | |
| IL286337A (he) | טיפול בסרטן עם נוגדנים ביספציפיים her2xcd3 בשילוב עם אנטי- her2 mab | |
| IL318426A (he) | שיטות לטיפול בסרטן הערמונין מטסטטי עמיד מפני סירוס באמצעות נוגדנים ביספציפיים נגד psma ונגד cd28 בשילוב עם נוגדנים נגד pd-1 | |
| CA3301695A1 (en) | Methods for treating prostate cancer with bispecific antibodies binding steap1xcd3 | |
| IL308393A (he) | נוגדנים לטיפול במחלות אלפא-סינוקליאיניות | |
| IL307556A (he) | שיטות לטיפול בסרטן באמצעות נוגדים כנגד tigit | |
| IL312813A (he) | שיטות לטיפול בסרטן במצעות נוגדנים דו-ספציפיים נגד cd3 ו-muc16 ונוגדנים נגד ctla-4 | |
| IL325956A (he) | שיטות לטיפול סרטן הערמונית מטסטטי עמיד לסירוס באמצעות נוגדנים דו-ספציפיים נגד psma ונגד cd28 | |
| IL320471A (he) | שיטות לטיפול בסרטן המבטא dll3 | |
| CA3306323A1 (en) | Anti-pd-l1 and anti-4-1bb bispecific antibody for treating tumors | |
| CA3297160A1 (en) | Method for treating prostate cancer | |
| HK40087378A (en) | Anti-ccr8 antibodies for treating cancer | |
| HK40128693A (zh) | 使用抗ctla4抗体治疗癌症的方法 | |
| CA3265829A1 (en) | METHODS OF CANCER TREATMENT USING ANTI-CTLA4 ANTIBODIES | |
| HK40108797A (en) | Methods for treating cancer using anti-ctla4 antibodies | |
| GB202412414D0 (en) | Methods for treating cancer | |
| ZA202302237B (en) | Prescription for treating prostate cancer | |
| IL311380A (he) | שיטות לטיפול בסרטן עם נוגדנים ביפרטופים אנטי- her2 |